提升的矩阵金属蛋白酶9型 (MMP-9) 转录在发生性移植患者中诱导血红蛋白后
Tor B B Petersen1, Subagini Nagarajah2, Martin Tepel1
1Department of Clinical Research, Department of Molecular Medicine, University of Southern Denmark, Campusvej 55, 5230 Odense, Denmark.
International journal of molecular sciences
|October 16, 2025
概括
接受球蛋白诱导疗法治疗的移植接受者显示出显著更高的矩阵金属蛋白酶9型 (MMP-9) 转录. 这表明,胸球蛋白可能会增加移植后的炎症反应,影响单核细胞中的MMP-9水平.
科学领域:
- 腎臟病學 (nephrology) 是一種醫學專業.
- 免疫学 免疫学 免疫学
- 分子生物学分子生物学
背景情况:
- 矩阵金属蛋白酶9型 (MMP-9) 与慢性病进展有关.
- 了解MMP-9在脏移植中的作用对于改善结果至关重要.
研究的目的:
- 调查捐赠者/接受者特征,诱导疗法和全移植功能对移植接受者的MMP-9转录的影响.
- 分析移植后外周血液单核细胞 (PBMC) 中MMP-9信使RNA (mRNA) 的水平.
主要方法:
- 量化实时PCR用于测量67名脏移植接受者的PBMC中的MMP-9转录.
- 使用德尔塔-德尔塔量化周期 (ΔΔCq) 方法量化了MMP-9水平.
- 数据是根据捐赠者类型,诱导疗法和全移植功能进行分析的.
主要成果:
- 不同的捐赠者类型 (AB0不兼容,活着,已故) 中,没有观察到中位数MMP-9转录的显著差异.
- 与其他疗法相比,接受胸球蛋白诱导疗法的移植接受者表现出明显更高的MMP-9中位数转录 (p=0.01).
- 延迟与即时全移植功能 (p=0.245) 的接受者之间,MMP-9转录水平没有显著差异.
结论:
- 用胸球蛋白的诱导疗法与PBMCs中MMP-9转录显著升高有关.
- 经过胆红蛋白治疗后MMP-9水平升高可能表明炎症反应增加.
- 需要进一步的研究来澄清MMP-9调制在移植中的临床影响.
更多相关视频
18:48In Vitro and In Vivo Assessment of T, B and Myeloid Cells Suppressive Activity and Humoral Responses from Transplant Recipients
Published on: August 12, 2017
14.8K
09:00TBase - an Integrated Electronic Health Record and Research Database for Kidney Transplant Recipients
Published on: April 13, 2021
5.2K
相关概念视频
Kidney Transplant I: Introduction
339
A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
339
Kidney Transplant II: Surgical Procedure
303
Preoperative ManagementThe primary goals of preoperative management in kidney transplantation are to optimize the patient’s metabolic state and prepare them for surgery through diet adjustments, necessary dialysis, and tailored medical treatment. This phase also involves comprehensive infection screening and patient education about the surgical procedure and postoperative care to improve outcomes and adherence.Medical ManagementA comprehensive evaluation is required for both the living...
303
Kidney Transplant III: Nursing Management
312
Postoperative Nursing Management for Kidney Transplant PatientsPostoperative nursing management care includes monitoring the surgical site, encouraging early movement, and promoting lung health through breathing exercises. Nurses also administer prescribed medications like H2-blockers, such as famotidine, or proton pump inhibitors, like omeprazole, to help prevent gastrointestinal ulcers and bleeding. Fungal infections in the mouth and bladder can result from immunosuppressive and antibiotic...
312
